Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAC-14028 Cream in Dermal Pruritus
NCT02052531Phase 2Completed
- Sponsor
- Amorepacific Corporation
- Start
- Jan 2013
- Primary completion
- Jun 2013
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of asivatrep in pruritus, Eczema and xerosis cutis (3 arms), sponsored by Amorepacific Corporation. Primary endpoint: Visual Analog Scale at Day 28. Started Jan 2013; status: completed.
02
Drugs
asivatrep
03
Conditions
pruritusEczemaxerosis cutis
Beyond the preview
Go deeper on NCT02052531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02052531.